Oxfendazole

This classification denotes an antihelminthic agent with the molecular formula C15H13N3O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier OMP2H17F9E, chemically known as 2-benzimidazolecarbamic acid, 5-(phenylsulfinyl)-, methyl ester but generally known as oxfendazole, which bears US NIH Compound Identifier 40854. European Medicines Agency schedules Oxfendazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09519MIG. The term OXFENDAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 30, No. 10 1976, List 16). OXFENDAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule oxfendazole under HS 29339990 and SITC 51577. As of Q4 2014, OXFENDAZOLE remains the US FDA Preferred Term for this commodity. Oxfendazole bears US NLM identifiers UMLS ID C0069761 and NCI Concept Code C75229. SMILES: S(=O)(C1CC2[NH]C(NC2CC1)NC(=O)OC)C1CCCCC1.